Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.

Trial Profile

Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2012

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Heart failure; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Aug 2012 New trial record
    • 01 Aug 2012 Results published in the Journal of Cardiothoracic and Vascular Anesthesia.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top